GKHT Medical Technology Co., Ltd. (SHE:301370)
China · Delayed Price · Currency is CNY 8.95
-0.17 (-1.86%)
Jun 10, 2026, 4:00 PM EDT
GKHT Medical Technology Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Net Income | 78.35 | 68.15 | 130.66 | 153.88 | 124.91 | 151.21 |
Depreciation & Amortization | 78.48 | 78.48 | 112.2 | 102.59 | 98.47 | 63.71 |
Other Amortization | 23.42 | 23.42 | 4.96 | 4.32 | 7.66 | 17.91 |
Loss (Gain) From Sale of Assets | -0.12 | -0.12 | 0.21 | 0.18 | -0.22 | 0.03 |
Asset Writedown & Restructuring Costs | 0.59 | 0.59 | 0.07 | 0.81 | 0.22 | 17.75 |
Loss (Gain) From Sale of Investments | 2.49 | 2.49 | 0.52 | - | - | - |
Provision & Write-off of Bad Debts | -4.58 | -4.58 | -8.89 | -14.92 | 27.12 | 23.9 |
Other Operating Activities | -183.56 | 118.59 | 92.51 | 126.75 | 160.97 | 157.59 |
Change in Accounts Receivable | 235.25 | 235.25 | 869.7 | 20.78 | -103.87 | 46.02 |
Change in Inventory | 125.67 | 125.67 | -54.21 | 305.77 | -52.93 | -123.8 |
Change in Accounts Payable | 52.48 | 52.48 | -497.5 | 25.11 | 227.6 | -60.9 |
Operating Cash Flow | 386.35 | 678.31 | 649.14 | 717.2 | 481.24 | 284.48 |
Operating Cash Flow Growth | -52.23% | 4.49% | -9.49% | 49.03% | 69.16% | - |
Capital Expenditures | -150.47 | -32.26 | -42.82 | -154.83 | -267.14 | -138.7 |
Sale of Property, Plant & Equipment | 0.04 | 0.05 | 0.51 | 0.43 | 0.08 | 2.82 |
Investing Cash Flow | -143.15 | -32.21 | -42.31 | -154.4 | -267.06 | -135.88 |
Long-Term Debt Issued | - | 1,026 | 1,299 | 1,650 | 2,974 | 3,023 |
Long-Term Debt Repaid | - | -1,544 | -1,559 | -3,037 | -2,756 | -2,895 |
Net Debt Issued (Repaid) | -339.12 | -518.09 | -260.22 | -1,387 | 218.9 | 128.29 |
Issuance of Common Stock | - | - | - | 843.21 | - | - |
Repurchase of Common Stock | -0.1 | - | -50.1 | - | - | - |
Common Dividends Paid | -69.68 | -67.25 | -110.56 | -99.58 | -122.02 | -128.78 |
Other Financing Activities | -35.53 | -58.77 | -8.95 | 23.04 | -62.26 | 7.97 |
Financing Cash Flow | -444.44 | -644.11 | -429.83 | -620.26 | 34.62 | 7.48 |
Foreign Exchange Rate Adjustments | -0.01 | -0.01 | -0.07 | - | - | - |
Net Cash Flow | -201.26 | 1.98 | 176.93 | -57.47 | 248.8 | 156.08 |
Free Cash Flow | 235.88 | 646.05 | 606.32 | 562.37 | 214.1 | 145.78 |
Free Cash Flow Growth | -69.30% | 6.55% | 7.81% | 162.67% | 46.87% | - |
Free Cash Flow Margin | 3.46% | 9.25% | 8.25% | 7.51% | 3.37% | 2.49% |
Free Cash Flow Per Share | 0.49 | 1.33 | 1.30 | 1.32 | 0.53 | 0.37 |
Cash Income Tax Paid | 183.06 | 179.6 | 184.92 | 236.92 | 174.39 | 195.56 |
Levered Free Cash Flow | -147.32 | 554.38 | 274.64 | 478.64 | 138.21 | 7.48 |
Unlevered Free Cash Flow | -128 | 575.85 | 312.73 | 533.75 | 212.78 | 88.08 |
Change in Working Capital | 391.29 | 391.29 | 316.89 | 343.59 | 62.1 | -147.62 |